Article Text

Download PDFPDF
CASE REPORT
Hidradenoma papilliferum: an unusual benign perianal tumour
  1. Ju Yong Cheong1,
  2. Cheok Soon Lee2,
  3. Christopher John Young1
  1. 1Colorectal Unit, Royal Prince Alfred Hospital, Newtown, New South Wales, Australia
  2. 2Cancer Pathology and Cell Biology, Western Sydney University School of Science and Health, Liverpool, New South Wales, Australia
  1. Correspondence to Professor Christopher John Young, cyoungnsw{at}aol.com

Summary

Hidradenoma papilliferum is an uncommon benign tumour that is located in the anogenital region of middle-aged women. They are usually only diagnosed after excision and are thought to arise from anogenital mammary-like glands. We present the case of a young woman who noticed a slow growing perianal lump which caused minimal symptoms.

  • gastrointestinal surgery
  • general surgery

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors CJY was involved in the concept and design, acquired the data, helped revise the article and completed and approved the final version submitted, and is accountable and in agreement with the final article. He is responsible for the overall content as guarantor, but has checked with and had approved by the other two authors the final draft submitted. JYC was involved in the concept and design after CJY approached him, and drafted the original manuscript, and approved the final version, and is accountable and in agreement with the final article. CSL was involved in the concept and design after CJY approached him, and revised the original draft after and before CJY redrafted it at separate time points, and approved the final version, and is accountable and in agreement with the final article. The final draft submitted was only possible by the contributions and approval of all three authors.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.